(Q42437852)

31 October 2017

title

Thickness of superficial basal cell carcinoma (sBCC) predicts imiquimod efficacy: a proposal for a thickness-based definition of sBCC. (English)

1 reference

superficial basal cell carcinoma

31 October 2017

main subject

1 reference

K M McKay

1

1 reference

31 October 2017

B L Sambrano

2

1 reference

31 October 2017

P S Fox

3

1 reference

31 October 2017

R L Bassett

4

1 reference

31 October 2017

S Chon

5

1 reference

31 October 2017

V G Prieto

6

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 September 2013

1 reference

British Journal of Dermatology

31 October 2017

published in

1 reference

31 October 2017

volume

169

1 reference

31 October 2017

issue

3

1 reference

31 October 2017

page(s)

549-554

1 reference

Skin cancer is among the most costly of all cancers to treat for the Medicare population

31 October 2017

cites work

1 reference

Cost of nonmelanoma skin cancer treatment in the United States

21 January 2018

1 reference

Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study

21 January 2018

1 reference

Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years

21 January 2018

1 reference

Management of nonmelanoma skin cancer in 2007.

21 January 2018

1 reference

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe

21 January 2018

1 reference

Management of superficial basal cell carcinoma: focus on imiquimod

21 January 2018

1 reference

Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review

21 January 2018

1 reference

Imiquimod: in superficial basal cell carcinoma

21 January 2018

1 reference

Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks

21 January 2018

1 reference

A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities

21 January 2018

1 reference

Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study

21 January 2018

1 reference

The value of typing basal cell carcinomas in predicting recurrence after surgical excision

21 January 2018

1 reference

Why classify basal cell carcinomas?

21 January 2018

1 reference

Histological classification of rodent ulcers and its bearing on their prognosis

21 January 2018

1 reference

The histogenesis of superficial basal-cell epitheliomas; unicentric or multicentric origin

21 January 2018

1 reference

Tumor thickness predicts long-term complete response of facial basal cell carcinomas in Asian skin types iv/v treated with methyl aminolaevulinate photodynamic therapy

21 January 2018

1 reference

High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study

21 January 2018

1 reference

A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage

21 January 2018

1 reference

Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response.

21 January 2018

1 reference

Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response

21 January 2018

1 reference

Basal cell carcinoma progression correlates with host immune response and stromal alterations: a histologic analysis.

21 January 2018

1 reference

Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo

21 January 2018

1 reference

Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma

21 January 2018

1 reference

Age and site prevalence of histologic subtypes of basal cell carcinomas

21 January 2018

1 reference

Basal cell carcinoma: histological classification and body-site distribution

21 January 2018

1 reference

Dermoscopy-guided surgery in basal cell carcinoma

21 January 2018

1 reference

Accuracy of biopsy sampling for subtyping basal cell carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJD.12402

1 reference

31 October 2017

1 reference